Bejar Rafael 4
4 · Aptose Biosciences Inc. · Filed Aug 23, 2021
Insider Transaction Report
Form 4
Bejar Rafael
Chief Medical Officer
Transactions
- Award
Performance Stock Option
2021-08-19+200,000→ 200,000 totalExercise: $2.35Exp: 2031-08-19→ Common Shares (200,000 underlying) - Award
Performance Stock Option
2021-08-19+200,000→ 200,000 totalExercise: $2.35Exp: 2031-08-19→ Common Shares (200,000 underlying)
Footnotes (3)
- [F1]The options were granted on August 19, 2021 and vest upon the earlier of (i) certain performance conditions or (ii) August 19, 2025, subject to Reporting Person's continued employment with the Issuer.
- [F2]Options vest in tranches connected with dose escalation trials.
- [F3]Options vest in connection with expansion trials.